Authors: Caliendo, AM Schuurman, R Yen-Lieberman, B Spector, SA Andersen, J Manjiry, R Crumpacker, C Lurain, NS Erice, A

Citation: Am. Caliendo et al., Comparison of quantitative and qualitative PCR assays for cytomegalovirus DNA in plasma, J CLIN MICR, 39(4), 2001, pp. 1334-1338

Authors: Crumpacker, C

Citation: C. Crumpacker, El 'Sur', CHICAGO REV, 47(1), 2001, pp. 71-71

Authors: Crumpacker, C

Citation: C. Crumpacker, 'Aquaphobic', CHICAGO REV, 47(1), 2001, pp. 72-72

Authors: Landry, ML Stanat, S Biron, K Brambilla, D Britt, W Jokela, J Chou, SW Drew, WL Erice, A Gilliam, B Lurain, N Manischewitz, J Miner, R Nokta, M Reichelderfer, P Spector, S Weinberg, A Yen-Lieberman, B Crumpacker, C

Citation: Ml. Landry et al., A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates, ANTIM AG CH, 44(3), 2000, pp. 688-692

Authors: Oram, RJ Marcellino, D Strauss, D Gustafson, E Talarico, CL Root, AK Sharma, PL Thompson, K Fingeroth, JD Crumpacker, C Herold, BC

Citation: Rj. Oram et al., Characterization of an acyclovir-resistant herpes simplex virus type 2 strain isolated from a premature neonate, J INFEC DIS, 181(4), 2000, pp. 1458-1461

Authors: Gulick, RM McAuliffe, V Holden-Wiltse, J Crumpacker, C Liebes, L Stein, DS Meehan, P Hussey, S Forcht, J Valentine, FT

Citation: Rm. Gulick et al., Phase I studies of hypericin, the active compound in St. John's Wort, as an antiretroviral agent in HIV-infected adults - AIDS clinical trials group protocols 150 and 258, ANN INT MED, 130(6), 1999, pp. 510-514